[{"Assets_0_Q3_USD":7377313000.0,"CommonStockSharesOutstanding_0_Q3_shares":103793000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":157933000.0,"NetIncomeLoss_1_Q3_USD":58920000.0,"NetIncomeLoss_3_Q3_USD":40208000.0,"StockholdersEquity_0_Q3_USD":2867516000.0,"EarningsPerShareBasic_1_Q3_USD":0.57,"EarningsPerShareBasic_3_Q3_USD":0.39,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":103594000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":103553000.0,"Ticker":"SYNH","CIK":"1610950","name":"SYNEOS HEALTH, INC.","OfficialName":"Syneos Health Inc. Class A Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"8107202548.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20191031"}]